Vol 76, No 9 (2018)

Date published: 2018-09-07

Table of Contents

open access

Editorials

The continued value of risk scores in advanced heart failure

Lars H. Lund

DOI: 10.5603/KP.2018.0181
Kardiol Pol 2018;76(9):1299-1300.

Mineralocorticoid receptor antagonists (MRAs): more attention required (to prescription)!

Stefania Paolillo, Guido Carlomagno

DOI: 10.5603/KP.2018.0182
Kardiol Pol 2018;76(9):1301-1302.
Original articles

Prognostic value of selected risk scales in patients with end-stage heart failure

Wioletta Szczurek, Bożena Szyguła-Jurkiewicz, Michał W. Zakliczyński, Bogumiła Król, Mariusz Gąsior, Marian Zembala

DOI: 10.5603/KP.a2018.0090
Kardiol Pol 2018;76(9):1320-1326.

Determinants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fraction

Rafał Dankowski, Tomasz Kotwica, Andrzej Szyszka, Monika Przewłocka-Kosmala, Wioletta Sacharczuk, Bożena Karolko, Małgorzata Kobusiak-Prokopowicz, Andrzej Mysiak, Wojciech Kosmala

DOI: 10.5603/KP.a2018.0128
Kardiol Pol 2018;76(9):1327-1335.

The influence of metformin and the presence of type 2 diabetes mellitus on mortality and hospitalisation in patients with heart failure

Arkadiusz Retwiński, Marcin Kosmalski, Marisa Crespo-Leiro, Aldo Maggioni, Grzegorz Opolski, Piotr Ponikowski, Lech Poloński, Ewa Jankowska, Jerzy Drzewoski, Jarosław Drożdż

DOI: 10.5603/KP.a2018.0127
Kardiol Pol 2018;76(9):1336-1343.

Visualisation of the oblique vein of the left atrium (vein of Marshall) using cardiac computed tomography: is the game worth the candle?

Rafał Młynarski, Agnieszka Młynarska, Krzysztof S. Gołba, Maciej Sosnowski

DOI: 10.5603/KP.a2018.0131
Kardiol Pol 2018;76(9):1344-1349.

Ten-year study of late electrotherapy complications. Single-centre analysis of indications and safety of transvenous leads extraction

Szymon J. Domagała, Michał Domagała, Jakub Chyła, Celina Wojciechowska, Marianna Janion, Anna Polewczyk

DOI: 10.5603/KP.a2018.0142
Kardiol Pol 2018;76(9):1350-1359.

The use of rotational atherectomy in high-risk patients: results from a high-volume centre

Piotr Kübler, Wojciech Zimoch, Michał Kosowski, Brunon Tomasiewicz, Oscar Rakotoarison, Artur Telichowski, Krzysztof Reczuch

DOI: 10.5603/KP.a2018.0144
Kardiol Pol 2018;76(9):1360-1368.
Reviews

Sex-specific differences in cardiac maladaptation to hypertension and arterial stiffening

Nicholas Cauwenberghs, Tatiana Kuznetsova

DOI: 10.5603/KP.a2018.0158
Kardiol Pol 2018;76(9):1303-1311.

Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes

Udaya S. Tantry, Eliano P. Navarese, Kevin P. Bliden, Paul A. Gurbel

DOI: 10.5603/KP.a2018.0159
Kardiol Pol 2018;76(9):1312-1319.
Clinical vignettes

Arteriovenous fistula imitating myocardial ischaemia on electrocardiogram

Paweł Moskal, Łukasz Klima, Marek Jastrzębski, Danuta Czarnecka

DOI: 10.5603/KP.2018.0185
Kardiol Pol 2018;76(9):1376.

Percutaneous mitral and tricuspid valve repair using edge-to-edge technique

Piotr Scisło, Adam Rdzanek, Arkadiusz Pietrasik, Agnieszka Kapłon-Cieślicka, Janusz Kochman

DOI: 10.5603/KP.2018.0186
Kardiol Pol 2018;76(9):1377.

Hybrid ablation in a patient with persistent, long-standing atrial fibrillation after left-sided pneumonectomy

Piotr Buchta, Michał Zembala, Krzysztof Myrda, Adam Józef Wojtaszczyk, Mateusz Witek, Mariusz Gąsior

DOI: 10.5603/KP.2018.0187
Kardiol Pol 2018;76(9):1378.

Successful anti-tachycardia pacing of a temporary implantable cardioverter-defibrillator used in the treatment of an arrhythmic storm

Anna Rydlewska, Krzysztof Boczar, Marcin Kuniewicz, Barbara Małecka, Jacek Lelakowski

DOI: 10.5603/KP.2018.0189
Kardiol Pol 2018;76(9):1380.

Successful treatment of intermediate-high–risk pulmonary embolism with aspiration thrombectomy: first experience in Poland

Marek Roik, Dominik Wretowski, Michał Machowski, Michał Ciurzyński, Marcin Krakowian, Piotr Pruszczyk

DOI: 10.5603/KP.2018.0190
Kardiol Pol 2018;76(9):1381.
Short communications

Safety profile of end-stage heart failure patients implanted with left ventricular assist devices. Krakow two-year observational all-comers study on left ventricular assist device recipients

Paweł Rubiś, Katarzyna Holcman, Bogusław Kapelak, Sylwia Wiśniowska-Śmiałek, Izabela Górkiewicz-Kot, Michał Kaleta, Rafał Drwiła, Hubert Hymczak, Irena Milaniak, Jolanta Siwińska, Maciej Stąpór, Dorota Sobczyk, Andrzej Gackowski, Robert Musiał, Piotr Podolec, Jadwiga Nessler, Karol Wierzbicki

DOI: 10.5603/KP.2018.0183
Kardiol Pol 2018;76(9):1369-1371.

Similar prevalence of platelet factor 4/heparin immunoglobulin G antibodies in patients following cardiac surgery and other patients suspected of heparin-induced thrombocytopaenia

Agata H. Bryk, Piotr Mazur, Joanna Zdziarska, Paweł Kuczia, Krzysztof Plens, Agata Leśniak-Sobelga, Ewa Wypasek, Anetta Undas

DOI: 10.5603/KP.2018.0184
Kardiol Pol 2018;76(9):1372-1375.
From the Editor

We can move forward

Anetta Undas

DOI: 10.5603/KP.2018.0179
Kardiol Pol 2018;76(9).
EHRA PRACTICAL GUIDE

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Jan Steffel, Peter Verhamme, Tatjana S. Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Ronan Collins, A. John Camm, Hein Heidbüchel

DOI: 10.5603/KP.2018.0180
Kardiol Pol 2018;76(9):1283-1298.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl